Cormorant Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Cormorant Asset Management’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,500	Closed	-$2.43M	–	108
2021 Q2	$2.43M	Sell	9,500 -3,833	-29%	-$957K	0.09%	92
2021 Q1	$3.54M	Hold	13,333	–	–	0.1%	102
2020 Q4	$4.92M	Sell	13,333 -1,651	-11%	-$474K	0.14%	85
2020 Q3	$3.66M	Sell	14,984 -8,349	-36%	-$2.6M	0.16%	81
2020 Q2	$6.72M	Sell	23,333 -3,838	-14%	-$1.13M	0.29%	67
2020 Q1	$5.54M	Sell	27,171 -609	-2%	-$194K	0.32%	57
2019 Q4	$12.4M	Sell	27,780 -5,483	-16%	-$1.95M	0.55%	49
2019 Q3	$10.2M	Sell	33,263 -5,070	-13%	-$1.65M	0.74%	45
2019 Q2	$12.2M	Buy	+38,333	New	+$13.3M	0.77%	41

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return